ReviewCurrent cancer drug targets2010

Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.

Hui-Wen LoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.